文献速递外周动脉疾病

终身保肢:以患者为中心的下肢动脉重建结局描述

Lifelong limb preservation: A patient-centered description of lower extremity arterial reconstruction outcomes.
PubMed 文献 · J Vasc Surg · 2017-05-11

研究基于2005-2013年单中心1006条因重症肢体缺血首次干预的肢体,提出终身保肢(LLP)指标,将死亡视为保肢成功而非删失。7年LLP为86%,而免截肢生存(AFS)仅14%,LLP在血管内与旁路手术间相似。LLP能更准确回答患者「我会不会失去腿」的问题。

要点

  • 7年LLP为86%,AFS仅14%,传统AFS严重低估保肢效果。
  • LLP在血管内与旁路手术间相似(7年86% vs 85%)。
  • 静息痛、溃疡、坏疽患者7年LLP分别为92%、86%、79%。

核心结论

  • 保肢效果的耐久性常超过患者预期寿命,LLP是更准确、以患者为中心的结局指标。

研究设计与样本

  • 回顾性队列研究,纳入2005-2013年单中心1006条因重症肢体缺血首次干预的肢体。

主要发现

  • 7年AFS为14%(561例事件),FFA为78%(123例事件),LLP为86%(123例事件)。
  • 血管内治疗与旁路手术的7年LLP相似(86% vs 85%)。
  • 静息痛、溃疡、坏疽患者7年LLP分别为92%、86%、79%。

关键数值与推荐

  • LLP定义截肢为失败,死亡不计为删失而视为保肢成功;30天内死亡在所有指标中均计为失败。

临床怎么用

  • 可用LLP向患者说明:溃疡患者血运重建后约86%概率不会失去腿,尽管无法保证生存时间。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Life expectancy is short for patients with critical limb ischemia (CLI), many of whom may fear amputation more than death. In light of the reduced life expectancy of these patients, the traditional 5-year freedom from amputation (FFA) statistic may not accurately address their concern. We developed a more relevant patient-centered calculation of major amputation risk during a patient's remaining lifetime to better answer the question, Will I ever lose my leg? METHODS: We identified all limbs undergoing first-time intervention for CLI in a large institutional database from 2005 to 2013. We calculated the traditional metrics of amputation-free survival (AFS, for which failure is death or amputation) and FFA (for which failure is amputation but deaths are censored and removed from further analysis). In addition, we propose a new term, lifelong limb preservation (LLP). LLP defines amputation as failure, but deaths are not censored and therefore reflect that LLP has been achieved. All deaths before 30 days were considered a failure in all three metrics, reflecting the risk of surgery. RESULTS: There were 1006 limbs identified as having first-time intervention for CLI (22% rest pain, 45% ulcer, 27% gangrene; 46% treated by angioplasty with or without stenting, 54% bypass). Using life-table analysis, 7-year AFS was 14% (561 events), FFA was 78% (123 events), and LLP was 86% (123 events). LLP was similar between patients undergoing angioplasty with or without stenting and bypass (7-year rates, 86% and 85%, respectively). For patients undergoing intervention for rest pain, 7-year rates were 14% for AFS, 84% for FFA, and 92% for LLP. For those undergoing treatment for ulcer, 7-year rates were 14% for AFS, 77% for FFA, and 86% for LLP. Finally, in those with gangrene, rates were 10% for AFS, 67% for FFA, and 79% for LLP. Using LLP, patients presenting with an ulcer can be told that although we cannot guarantee how long they will live, with revascularization there is approximately an 86% chance they will not lose the leg. CONCLUSIONS: These results show that the durability of our limb preservation efforts often exceeds the life expectancy of our patients. Using LLP as an outcomes assessment provides a more accurate and patient-centered answer to the question, If I have this procedure, will I ever lose my leg?

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Shean KE, Soden PA, Schermerhorn ML, et al. Lifelong limb preservation: A patient-centered description of lower extremity arterial reconstruction outcomes. J Vasc Surg. 2017. PMID: 28502548. doi:10.1016/j.jvs.2017.02.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。